Xinxing Du

467 total citations
28 papers, 288 citations indexed

About

Xinxing Du is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Xinxing Du has authored 28 papers receiving a total of 288 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 12 papers in Molecular Biology and 9 papers in Cancer Research. Recurrent topics in Xinxing Du's work include Prostate Cancer Treatment and Research (15 papers), Prostate Cancer Diagnosis and Treatment (6 papers) and Extracellular vesicles in disease (4 papers). Xinxing Du is often cited by papers focused on Prostate Cancer Treatment and Research (15 papers), Prostate Cancer Diagnosis and Treatment (6 papers) and Extracellular vesicles in disease (4 papers). Xinxing Du collaborates with scholars based in China, United States and South Korea. Xinxing Du's co-authors include Wei Xue, Baijun Dong, Yuxiang Fang, Wei‐Qiang Gao, Jiahua Pan, Jialin Wang, Yinjie Zhu, Liancheng Fan, Baijun Dong and Junxia Xie and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Small.

In The Last Decade

Xinxing Du

26 papers receiving 287 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinxing Du China 8 144 133 132 62 26 28 288
Guilong Tanzhu China 8 169 1.2× 87 0.7× 84 0.6× 119 1.9× 32 1.2× 15 349
Ruiying Sun China 12 206 1.4× 66 0.5× 110 0.8× 54 0.9× 33 1.3× 28 327
Fangzhou Ye China 9 174 1.2× 102 0.8× 133 1.0× 77 1.2× 27 1.0× 23 341
Danbi Seo South Korea 4 178 1.2× 67 0.5× 123 0.9× 56 0.9× 28 1.1× 6 328
Zining Jin China 11 186 1.3× 61 0.5× 136 1.0× 74 1.2× 25 1.0× 28 309
Marta De Menna Switzerland 10 246 1.7× 64 0.5× 155 1.2× 85 1.4× 27 1.0× 15 379
Brijesh Kumar United States 11 168 1.2× 53 0.4× 99 0.8× 94 1.5× 31 1.2× 18 314
Navchaa Gombodorj Japan 11 174 1.2× 67 0.5× 103 0.8× 113 1.8× 29 1.1× 20 305
Wumin Dai China 8 142 1.0× 90 0.7× 98 0.7× 78 1.3× 38 1.5× 20 271
Yiyi Ji China 7 166 1.2× 99 0.7× 105 0.8× 85 1.4× 51 2.0× 13 309

Countries citing papers authored by Xinxing Du

Since Specialization
Citations

This map shows the geographic impact of Xinxing Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinxing Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinxing Du more than expected).

Fields of papers citing papers by Xinxing Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinxing Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinxing Du. The network helps show where Xinxing Du may publish in the future.

Co-authorship network of co-authors of Xinxing Du

This figure shows the co-authorship network connecting the top 25 collaborators of Xinxing Du. A scholar is included among the top collaborators of Xinxing Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinxing Du. Xinxing Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Du, Xinxing, et al.. (2025). ATOH8 confers the vulnerability of tumor cells to ferroptosis by repressing SCD expression. Cell Death and Differentiation. 32(8). 1397–1412. 1 indexed citations
3.
Chen, Tianyi, Xiaorong Pu, Junyao Xu, et al.. (2025). Osalmid sensitizes clear cell renal cell carcinoma to navitoclax through a STAT3/BCL-XL pathway. Cancer Letters. 613. 217514–217514. 2 indexed citations
4.
Du, Xinxing, Jiayi Wang, Jiazhou Liu, et al.. (2024). Precise diagnosis and risk stratification of prostate cancer by comprehensive serum metabolic fingerprints: a prediction model study. International Journal of Surgery. 110(3). 1450–1462. 4 indexed citations
5.
Du, Xinxing, et al.. (2024). Modelling the tumor microenvironment in vitro in prostate cancer: current and future perspectives. SHILAP Revista de lepidopterología. 5(5). 7 indexed citations
6.
Nan, Jing, et al.. (2024). PAX6 promotes neuroendocrine phenotypes of prostate cancer via enhancing MET/STAT5A-mediated chromatin accessibility. Journal of Experimental & Clinical Cancer Research. 43(1). 144–144. 5 indexed citations
7.
8.
Wu, Xinrui, Yinjie Zhu, Cong Hu, et al.. (2024). Extracellular vesicles related gene HSPH1 exerts anti-tumor effects in prostate cancer via promoting the stress response of CD8 + T cells. Cellular Oncology. 47(3). 1059–1064. 7 indexed citations
9.
Xie, Shaowei, Jiayi Wang, Yicheng Zhu, et al.. (2023). Engineering the MoS2/MXene Heterostructure for Precise and Noninvasive Diagnosis of Prostate Cancer with Clinical Specimens. Advanced Science. 10(15). e2206494–e2206494. 20 indexed citations
10.
Du, Xinxing, Yiming Gong, Jiazhou Liu, et al.. (2023). Early Plasma Circulating Tumor DNA as a Potential Biomarker of Disease Recurrence in Non-metastatic Prostate Cancer. Cancer Research and Treatment. 55(3). 969–977. 8 indexed citations
11.
Du, Xinxing, et al.. (2023). Taurine Inhibits Ferroptosis Mediated by the Crosstalk between Tumor Cells and Tumor‐Associated Macrophages in Prostate Cancer. Advanced Science. 11(3). e2303894–e2303894. 50 indexed citations
12.
Du, Xinxing, Yanhao Dong, Liancheng Fan, et al.. (2023). Early serial circulating tumor DNA sequencing predicts the efficacy of chemohormonal therapy in patients with metastatic hormone-sensitive prostate cancer. Translational Oncology. 34. 101701–101701. 3 indexed citations
13.
14.
Dong, Baijun, Bin Yang, Wei Chen, et al.. (2022). Olaparib for Chinese metastatic castration-resistant prostate cancer: A real-world study of efficacy and gene predictive analysis. Medical Oncology. 39(8). 96–96. 6 indexed citations
15.
Dong, Liang, Xinxing Du, Changxue Lu, et al.. (2022). RNA profiling of circulating tumor cells systemically captured from diagnostic leukapheresis products in prostate cancer patients. Materials Today Bio. 17. 100474–100474. 6 indexed citations
16.
Wang, Jialin, Xinxing Du, Xiao Wang, et al.. (2021). Tumor-derived miR-378a-3p-containing extracellular vesicles promote osteolysis by activating the Dyrk1a/Nfatc1/Angptl2 axis for bone metastasis. Cancer Letters. 526. 76–90. 33 indexed citations
17.
Wang, Yanqing, Yuxiang Fang, Baijun Dong, et al.. (2020). Discovery of extracellular vesicles derived miR-181a-5p in patient's serum as an indicator for bone-metastatic prostate cancer. Theranostics. 11(2). 878–892. 39 indexed citations
18.
Fan, Liancheng, Yinjie Zhu, Jiahua Pan, et al.. (2020). Comparative Analysis of Genomic Alterations across Castration Sensitive and Castration Resistant Prostate Cancer via Circulating Tumor DNA Sequencing. The Journal of Urology. 205(2). 461–469. 33 indexed citations
19.
Du, Xinxing, et al.. (2017). Interleukin-6 regulates iron-related proteins through c-Jun N-terminal kinase activation in BV2 microglial cell lines. PLoS ONE. 12(7). e0180464–e0180464. 26 indexed citations
20.
Du, Xinxing, et al.. (2016). [Association between remnant lipoprotein-cholesterol and coronary heart disease].. PubMed. 44(8). 657–60. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guilong Tanzhu Breakdown of academic impact, for papers by Ruiying Sun Breakdown of academic impact, for papers by Fangzhou Ye Breakdown of academic impact, for papers by Danbi Seo Breakdown of academic impact, for papers by Zining Jin Breakdown of academic impact, for papers by Marta De Menna Breakdown of academic impact, for papers by Brijesh Kumar Breakdown of academic impact, for papers by Navchaa Gombodorj Breakdown of academic impact, for papers by Wumin Dai Breakdown of academic impact, for papers by Yiyi Ji
Rankless by CCL
2026